Showing results (231-240 of 259) with videos related to
Sort By:
Pageof 26
Advanced Materials (Deerfield Beach, Fla.)|December 17, 2013
2-dimensional transition metal dichalcogenides with tunable direct band gaps: MoS₂(₁-x) Se₂x monolayersJohn Mann, Quan Ma, Patrick M Odenthal, et al.BMC Gastroenterology|March 8, 2020
The effect of prophylactic hemoclips on the risk of delayed post-endoscopic mucosal resection bleed for upper and lower gastrointestinal lesions: a retrospective cohort studyKaren Chang, Brian S Lee, Timnit Tekeste, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2019
3-Year Freedom from Progression After <sup>68</sup>Ga-PSMA PET/CT-Triaged Management in Men with Biochemical Recurrence After Radical Prostatectomy: Results of a Prospective Multicenter TrialLouise Emmett, Reuben Tang, Rohan Nandurkar, et al.ACS Nano|April 2, 2014
Postgrowth tuning of the bandgap of single-layer molybdenum disulfide films by sulfur/selenium exchangeQuan Ma, Miguel Isarraraz, Chen S Wang, et al.European Urology|March 28, 2026
Prospective Comparison of <sup>64</sup>Copper [<sup>64</sup>Cu]SAR-bisPSMA vs <sup>68</sup>Gallium[<sup>68</sup>Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial)Sobia Khan, Nathan Papa, Andrew Kneebone, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2025
Diagnostic Potential of <sup>68</sup>Ga-NeoB PET/CT with Estrogen Receptor- and Progesterone Receptor-Positive Breast Cancer Undergoing Staging or Restaging for Metastatic DiseaseZahra Sabahi, Andrew Nguyen, Keith Wong, et al.Cell Reports. Medicine|November 18, 2020
Human Tumor-Infiltrating MAIT Cells Display Hallmarks of Bacterial Antigen Recognition in Colorectal CancerShamin Li, Yannick Simoni, Etienne Becht, et al.American Journal of Lifestyle Medicine|November 18, 2024
Improving Medical Student Access to Nutrition During the Core Surgery ClerkshipBlake M Hauser, Matthew Parsons, Besmira Alija, et al.The Lancet. Oncology|August 2, 2025
Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant prostate cancer in ENZA-p (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trialLouise Emmett, Nathan Papa, Shalini Subramaniam, et al.Nature Cancer|April 15, 2026
Predictive value of early PSMA upregulation for the response to enzalutamide ± <sup>177</sup>Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: substudy of the randomized, phase 2 ENZA-p trialLouise Emmett, Mina Swiha, Nathan Papa, et al.Pageof 26